Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Treasury Shares (2016 - 2025)

Collegium Pharmaceutical has reported Treasury Shares over the past 6 years, most recently at $222.5 million for Q4 2025.

  • Quarterly results put Treasury Shares at $222.5 million for Q4 2025, up 12.66% from a year ago — trailing twelve months through Dec 2025 was $222.5 million (up 12.66% YoY), and the annual figure for FY2025 was $222.5 million, up 12.66%.
  • Treasury Shares for Q4 2025 was $9.0 million at Collegium Pharmaceutical, roughly flat from $9.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for COLL hit a ceiling of $9.0 million in Q3 2025 and a floor of -$859040.0 in Q3 2021.
  • Median Treasury Shares over the past 5 years was $2.7 million (2023), compared with a mean of $3.8 million.
  • Biggest five-year swings in Treasury Shares: surged 210.54% in 2022 and later increased 12.66% in 2025.
  • Collegium Pharmaceutical's Treasury Shares stood at $42.9 million in 2021, then surged by 44.48% to $61.9 million in 2022, then skyrocketed by 121.85% to $137.4 million in 2023, then soared by 43.76% to $197.5 million in 2024, then grew by 12.66% to $222.5 million in 2025.
  • The last three reported values for Treasury Shares were $222.5 million (Q4 2025), $222.5 million (Q3 2025), and $217.5 million (Q2 2025) per Business Quant data.